Literature DB >> 32098724

Case Report: Carfilzomib-induced Thrombotic Microangiopathy With Complement Activation Treated Successfully With Eculizumab.

Divaya Bhutani1, Amer Assal2, Markus Y Mapara2, Samantha Prinzing2, Suzanne Lentzsch2.   

Abstract

Entities:  

Keywords:  Carfilzomib; Complement activation; Eculizumab; Hemolytic uremic syndrome; Thrombotic microangiopathy

Mesh:

Substances:

Year:  2020        PMID: 32098724     DOI: 10.1016/j.clml.2020.01.016

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


× No keyword cloud information.
  2 in total

1.  Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma.

Authors:  Michael Rassner; Rebecca Baur; Andreas Mackensen; Monika Engelhardt; Ralph Wäsch; Mario Schiffer; Johanna Schneider
Journal:  BMC Nephrol       Date:  2021-01-18       Impact factor: 2.388

2.  Carfilzomib-Induced Thrombotic Microangiopathy: Focus on Pathogenesis.

Authors:  Odianosen Eigbire-Molen; Daniela Hermelin; Douglas Blackall
Journal:  J Med Cases       Date:  2022-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.